[unable to retrieve full-text content]

A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill - olaparib (Lynparza) - works by blocking a natural enzyme called PARP that normally fixes DNA damage in healthy...